Rhodes Pharmaceuticals' FDA approval of ANDA205853 facilitates the entry of a generic alternative, a maneuver expected to broaden the company's revenu...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
**TEXT:** Lifestar Pharma LLC received FDA approval for its Abbreviated New Drug Application for Oral Capecitabine under #ANDA211724. Market analysts ...
# FDA Approves Generic Drug Application for Granules India Granules India received FDA approval for ANDA213469 on April 24, 2020, positioning the com...
Chartwell Governmental & Specialty RX, LLC. announced the approval of its generic acyclovir ANDA (app# ANDA212718), which significantly broadens marke...
FDA has granted approval to GENUS for generic medication associated with ANDA207108, marking a continuation of the company's push into specified thera...
UMEDICA has secured FDA approval for its generic drug candidate referenced by ANDA207798. This authorization is expected to bolster the company's mark...
Amneal Pharmaceuticals NY LLC received U.S. approval on Tuesday for its generic version of the transdermal opioid buprenorphine film, marking a new of...
Ajanta Pharma USA Inc. has announced the FDA approval of its abbreviated new drug application (ANDA213651) for Metformin Hydrochloride, representing a...
Zydus Pharmaceuticals USA Inc. received FDA approval for its generic oral tablets of Lamotrigine under ANDA207763, a move that is expected to heighten...
Rhodes Pharmaceuticals LLC announced today that its application (ANDA205601) for the generic sublingual combination of buprenorphine and naloxone has ...
Laurus Labs Limited announced the approval of the ANDA for fenofibrate oral tablets, enabling it to compete in the U.S. cholesterol-lowering market fo...
VistaPharm, LLC announced the FDA approval of its methadone hydrochloride oral solution, effectively adding a new competitor to the market for a contr...
TRUPHARMA LLC secured U.S. approval for its generic Metformin Hydrochloride Oral Solution, expanding the supply chain for the widely used Type 2 diabe...
The FDA approved Lundbeck’s intravenous CGRP inhibitor VYEPTI for the prevention of episodic migraine, positioning the company to capitalize on the lu...
Agile Therapeutics, Inc. secured FDA approval for Twirla (levonorgestrel/ethinyl estradiol) transdermal gel, positioning the company to compete in a c...
Pharmaceutical manufacturer SANALUZ announced FDA approval for a generic drug via ANDA 211690, a strategic milestone that is expected to bolster the c...
Chartwell RX, LLC announced the FDA approval of its generic methotrexate sodium tablets for the treatment of several conditions, positioning the compa...
Aurolife Pharma, LLC received FDA approval for its oxycodone hydrochloride oral solution, a development expected to bolster generic competition and po...
On January 27, 2020, BluePoint Laboratories received FDA approval for its ANDA No. 210986 to manufacture generic diclofenac sodium topical gel, 1%, di...
Accord Healthcare Inc. has won FDA approval for the generic version of methotrexate sodium, widening the competitive landscape for this widely prescri...